v3.26.1
Research and Development Revenue (Tables)
 6 Months Ended
Jun. 30, 2026
Research and Development Revenue [Abstract]  
Schedule of Revenues Disaggregated

For the three and six months ended June 30, 2026 and 2025, the Company’s revenues disaggregated by the major sources were as follows (in thousands):

 

    Three Months Ended
June 30,		     Six Months Ended
June 30,		  
    2026     2025     2026     2025  
BARDA   $ 3,279     $ 4,649     $ 6,589     $ 11,030  
Other U.S. governmental authorities     245       416       926       742  
Total revenue   $ 3,524     $ 5,065     $ 7,515     $ 11,772  
Schedule of Company's Contract Liabilities The following table presents the activity in the Company’s contract assets during the six months ended June 30, 2026:
    December 31,
2025
Balance		     Additions     Reductions     June 30,
2026
Balance		  
    (in thousands)  
Contract assets:                        
Unbilled revenue   $ 849     $ 722     $ (496 )   $ 1,075  
Total contract assets   $ 849     $ 722     $ (496 )   $ 1,075  

The following table presents the activity in the Company’s contract liabilities during the six months ended June 30, 2026:

 

    December 31,
2025
Balance		     Additions     Reductions     June 30,
2026
Balance		  
    (in thousands)  
Contract liabilities:                        
Deferred revenue   $ 154     $ 80     $ (213 )   $ 21  
Total contract liabilities   $ 154     $ 80     $ (213 )   $ 21